Ying Wang

发表

Rational design of antibody protease inhibitors.

P. Schultz, Rongsheng E. Wang, Xiaozhou Luo, 2015, Journal of the American Chemical Society.

Rational design of a Kv1.3 channel-blocking antibody as a selective immunosuppressant

P. Schultz, Rongsheng E. Wang, A. Theofilopoulos, 2016, Proceedings of the National Academy of Sciences.

Human Adipose-Derived Mesenchymal Stem Cells Are Resistant to HBV Infection during Differentiation into Hepatocytes in Vitro

Haiying Chen, Feng Wang, Kaiyu Zhang, 2014, International journal of molecular sciences.

A tumor-targeted immune checkpoint blocker

P. Schultz, Rongsheng E. Wang, Shuhong Li, 2019, Proceedings of the National Academy of Sciences.

Identification of Ala2Thr mutation in insulin gene from a Chinese MODY10 family

Y. Wang, M. Jiang, Rong Zhang, 2020, Molecular and Cellular Biochemistry.

An antibody CDR3-erythropoietin fusion protein.

P. Schultz, Feng Wang, Yong Zhang, 2013, ACS chemical biology.

N-myristoyltransferase-1 is necessary for lysosomal degradation and mTORC1 activation in cancer cells

T. Chou, Marian S. Navarrete, Delphine J. Lee, 2020, Scientific Reports.

The first E59Q mutation identified in the NEUROD1 gene in a Chinese family with maturity-onset diabetes of the young: an observational study

Li Li, M. Jiang, Ying Wang, 2020 .

Multifunctional Antibody Agonists Targeting Glucagon-like Peptide-1, Glucagon, and Glucose-Dependent Insulinotropic Polypeptide Receptors.

P. Schultz, Pengyu Yang, Feng Wang, 2016, Angewandte Chemie.

Synthesis and characterization of Si3N4 thin nanobelts via direct nitridation of Si powders

Xiang-Yun Guo, Ying Wang, G. Jin, 2008 .

High Interleukin-6 Levels Are Associated With Large-Artery Atherosclerotic Stroke

T. Tung, Feng Wang, Ying Wang, 2023, The neurologist.

Rational design of a humanized glucagon-like peptide-1 receptor agonist antibody.

P. Schultz, Feng Wang, Yong Zhang, 2015, Angewandte Chemie.

Functional human antibody CDR fusions as long-acting therapeutic endocrine agonists

P. Schultz, Xiaozhou Luo, Feng Wang, 2015, Proceedings of the National Academy of Sciences.

Rational design of humanized dual-agonist antibodies.

P. Schultz, Feng Wang, Yong Zhang, 2015, Journal of the American Chemical Society.

An Epitope-Specific Respiratory Syncytial Virus Vaccine Based on an Antibody Scaffold.

P. Schultz, Rongsheng E. Wang, Juanjuan Du, 2015, Angewandte Chemie.

An immunosuppressive antibody-drug conjugate.

Yu Cao, Feng Wang, Peter G Schultz, 2015, Journal of the American Chemical Society.

Rational Design of CXCR4 Specific Antibodies with Elongated CDRs

P. Schultz, M. Hull, Feng Wang, 2014, Journal of the American Chemical Society.

Targeting HDAC3 to overcome the resistance to ATRA or arsenic in acute promyelocytic leukemia through ubiquitination and degradation of PML-RARα

Jun Yu Li, Jiong Hu, A. Liang, 2022, Cell Death & Differentiation.

Engineering Bifunctional Antibodies with Constant Region Fusion Architectures.

Chan Hyuk Kim, P. Schultz, Yu Cao, 2017, Journal of the American Chemical Society.

An immunosuppressive antibody-drug conjugate.

Matthew S. Tremblay, Chan Hyuk Kim, P. Schultz, 2015, Journal of the American Chemical Society.

Targeting HDAC3 to overcome the resistance to ATRA or arsenic in acute promyelocytic leukemia through ubiquitination and degradation of PML-RARα

Jun Yu Li, Jiong Hu, A. Liang, 2023, Cell Death & Differentiation.

Multifunctional Antibody Agonists Targeting Glucagon-like Peptide-1, Glucagon, and Glucose-Dependent Insulinotropic Polypeptide Receptors.

P. Schultz, Pengyu Yang, Feng Wang, 2016, Angewandte Chemie.

Rational Design of Dual Agonist-Antibody Fusions as Long-acting Therapeutic Hormones.

P. Schultz, Feng Wang, Danling Wang, 2016, ACS chemical biology.